Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Helmlinger

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|December 15, 2020
Longitudinal Tumor Size and Neutrophil-to-Lymphocyte Ratio Are Prognostic Biomarkers for Overall Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With DurvalumabSergey Gavrilov, Kirill Zhudenkov, Gabriel Helmlinger, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 7, 2010
Understanding pharmacokinetics using realistic computational models of fluid dynamics: biosimulation of drug distribution within the CSF space for intrathecal drugsAndreas Kuttler, Thomas Dimke, Steven Kern, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 11, 2017
Multiscale Mathematical Model of Drug-Induced Proximal Tubule Injury: Linking Urinary Biomarkers to Epithelial Cell Injury and Renal DysfunctionYeshitila Gebremichael, James Lu, Harish Shankaran, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 22, 2022
A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnosticsKirill Zhudenkov, Sergey Gavrilov, Alina Sofronova, et al.
Frontiers in Immunology|March 29, 2024
Mathematical modeling in autoimmune diseases: from theory to clinical applicationYaroslav Ugolkov, Antonina Nikitich, Cristina Leon, et al.
Diabetes, Obesity & Metabolism|April 18, 2018
Exenatide effects on gastric emptying rate and the glucose rate of appearance in plasma: A quantitative assessment using an integrative systems pharmacology modelVeronika Voronova, Kirill Zhudenkov, Robert C Penland, et al.
Frontiers in Immunology|February 14, 2025
Corrigendum: Mathematical modeling in autoimmune diseases: from theory to clinical applicationYaroslav Ugolkov, Antonina Nikitich, Cristina Leon, et al.
Computational and Structural Biotechnology Journal|October 17, 2024
Assessment of NSCLC disease burden: A survival model-based meta-analysis studyNataliya Kudryashova, Boris Shulgin, Nikolai Katuninks, et al.
NPJ Systems Biology and Applications|December 20, 2018
Mathematical model of hemodynamic mechanisms and consequences of glomerular hypertension in diabetic miceHari Shankar Mahato, Christine Ahlstrom, Rasmus Jansson-Löfmark, et al.
NPJ Systems Biology and Applications|March 12, 2019
Erratum: Publisher Correction: Mathematical model of hemodynamic mechanisms and consequences of glomerular hypertension in diabetic miceHari Shankar Mahato, Christine Ahlstrom, Rasmus Jansson-Löfmark, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
CPT: Pharmacometrics & Systems Pharmacology|December 15, 2020
Longitudinal Tumor Size and Neutrophil-to-Lymphocyte Ratio Are Prognostic Biomarkers for Overall Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With DurvalumabSergey Gavrilov, Kirill Zhudenkov, Gabriel Helmlinger, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 7, 2010
Understanding pharmacokinetics using realistic computational models of fluid dynamics: biosimulation of drug distribution within the CSF space for intrathecal drugsAndreas Kuttler, Thomas Dimke, Steven Kern, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 11, 2017
Multiscale Mathematical Model of Drug-Induced Proximal Tubule Injury: Linking Urinary Biomarkers to Epithelial Cell Injury and Renal DysfunctionYeshitila Gebremichael, James Lu, Harish Shankaran, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 22, 2022
A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnosticsKirill Zhudenkov, Sergey Gavrilov, Alina Sofronova, et al.
Frontiers in Immunology|March 29, 2024
Mathematical modeling in autoimmune diseases: from theory to clinical applicationYaroslav Ugolkov, Antonina Nikitich, Cristina Leon, et al.
Diabetes, Obesity & Metabolism|April 18, 2018
Exenatide effects on gastric emptying rate and the glucose rate of appearance in plasma: A quantitative assessment using an integrative systems pharmacology modelVeronika Voronova, Kirill Zhudenkov, Robert C Penland, et al.
Frontiers in Immunology|February 14, 2025
Corrigendum: Mathematical modeling in autoimmune diseases: from theory to clinical applicationYaroslav Ugolkov, Antonina Nikitich, Cristina Leon, et al.
Computational and Structural Biotechnology Journal|October 17, 2024
Assessment of NSCLC disease burden: A survival model-based meta-analysis studyNataliya Kudryashova, Boris Shulgin, Nikolai Katuninks, et al.
NPJ Systems Biology and Applications|December 20, 2018
Mathematical model of hemodynamic mechanisms and consequences of glomerular hypertension in diabetic miceHari Shankar Mahato, Christine Ahlstrom, Rasmus Jansson-Löfmark, et al.
NPJ Systems Biology and Applications|March 12, 2019
Erratum: Publisher Correction: Mathematical model of hemodynamic mechanisms and consequences of glomerular hypertension in diabetic miceHari Shankar Mahato, Christine Ahlstrom, Rasmus Jansson-Löfmark, et al.
Pageof 5